Skip to main content

Articles

Page 4 of 83

  1. Glioblastoma multiforme (GBM) exhibits a cellular hierarchy with a subpopulation of stem-like cells known as glioblastoma stem cells (GSCs) that drive tumor growth and contribute to treatment resistance. NAD(H...

    Authors: Wentao Hu, Xiaoteng Cui, Hongyu Liu, Ze Li, Xu Chen, Qixue Wang, Guolu Zhang, Er Wen, Jinxin Lan, Junyi Chen, Jialin Liu, Chunsheng Kang and Ling Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:3
    Content type: Research Published on:

  2. SERPINE1 mediates the transfer of cancer-derived exosomal let-7 g-5p to promote macrophage M2 polarization.

    Authors: Zhenzhen Ye, Jianfeng Yi, Xiangyan Jiang, Wengui Shi, Hao Xu, Hongtai Cao, Long Qin, Lixin Liu, Tianming Wang, Zhijian Ma and Zuoyi Jiao
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:2
    Content type: Research Published on:

  3. Targeting the TGF-β pathway in tumor therapy has proven challenging due to the highly context-dependent functions of TGF-β. Integrin αvβ8, a pivotal activator of TGF-β, has been implicated in TGF-β signaling w...

    Authors: Cuicui Guo, Hui Sun, Yulei Du, Xiaodong Dai, Yu Pang, Zhen Han, Xinhui Xiong, Shaowei Li, Junhua Zhang, Qingbing Zheng and Xun Gui
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:1
    Content type: Research Published on:

  4. Multiple Myeloma (MM) is the second most common hematological malignancy, characterized by the accumulation of monoclonal plasmocytes in the bone marrow. Despite advancements with proteasome inhibitors, immuno...

    Authors: Jessy Sirera, Saharnaz Sarlak, Manon Teisseire, Alexandrine Carminati, Victoria J. Nicolini, Coline Savy, Patrick Brest, Thierry Juel, Christophe Bontoux, Marcel Deckert, Mickael Ohanna, Sandy Giuliano, Maeva Dufies, Gilles Pages and Frederic Luciano
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:335
    Content type: Research Published on:

  5. On September 23–24 (2024) the 6th Workshop IRE on Translational Oncology, titled “Cancer Organoids as Reliable Disease Models to Drive Clinical Development of Novel Therapies,” took place at the IRCCS Regina E...

    Authors: Giovanni Blandino, Ronit Satchi-Fainaro, Ingeborg Tinhofer, Giovanni Tonon, Sarah C. Heilshorn, Yong-Jun Kwon, Ana Pestana, Carlotta Frascolla, Luca Pompili, Aurora Puce, Sara Iachettini, Annalisa Tocci, Sofia Karkampouna, Marianna Kruithof-de Julio, Piera Tocci, Nicla Porciello…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:334
    Content type: Meeting Report Published on:

  6. Authors: Bisheng Cheng, Lingfeng Li, Tianlong Luo, Qiong Wang, Yong Luo, Shoumin Bai, Kaiwen Li, Yiming Lai and Hai Huang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:333
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2024 43:67

  7. Head and neck squamous cell carcinoma (HNSCC) is a very aggressive disease characterized by a heterogeneous tumor immune microenvironment (TIME). Tumor-associated macrophages (TAMs) constitute the major innate...

    Authors: Chun Liu, Kun Wu, Chuwen Li, Zhen Zhang, Peisong Zhai, Haiyan Guo and Jianjun Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:332
    Content type: Research Published on:

  8. Liquid biopsies offer less burdensome sensitive disease monitoring. Bone marrow (BM) metastases, common in various cancers including neuroblastoma, is associated with poor outcomes. In pediatric high-risk neur...

    Authors: Lieke M. J. van Zogchel, Boris Decarolis, Esther M. van Wezel, Lily Zappeij‐Kannegieter, Nina U. Gelineau, Roswitha Schumacher‐Kuckelkorn, Thorsten Simon, Frank Berthold, Max M. van Noesel, Marta Fiocco, C. Ellen van der Schoot, Barbara Hero, Janine Stutterheim and Godelieve A. M. Tytgat
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:331
    Content type: Research Published on:

  9. Osteosarcoma (OS), the most prevalent primary malignant bone tumor in children and adolescents, arises from bone-forming mesenchymal cells. Despite advancements in surgical resection and neoadjuvant chemothera...

    Authors: Zehang Zheng, Yunhao Zeng, Xing Bao, Chuang Huang, Fengjing Guo, Fei Xu and Zhengqiang Luo
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:330
    Content type: Research Published on:

  10. Ductal carcinoma in situ (DCIS) is a noninvasive breast disease that variably progresses to invasive breast cancer (IBC). Given the unpredictability of this progression, most DCIS patients are aggressively man...

    Authors: Taylor S. Hulahan and Peggi M. Angel
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:329
    Content type: Review Published on:

  12. Malignant pleural mesothelioma (MPM) is a highly chemo-refractory and immune-evasive tumor that presents a median overall survival of 12–14 months when treated with chemotherapy and immunotherapy. New anti-tum...

    Authors: I. C. Salaroglio, P. Aviles, J. Kopecka, A. Merlini, F. Napoli, L. Righi, S. Novello, H. Sullivan, C. Cuevas, G. V. Scagliotti and C. Riganti
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:327
    Content type: Research Published on:

  13. The immune landscape associated with different subtypes of intestinal metaplasia (IM) and early gastric cancer (EGC) remains unclear. This study aimed to investigate the immune landscape of complete intestinal...

    Authors: Yuxin He, Jiayu Wang, Zilin Deng, Huang Feng, Mingzhan Du, Deqing Zhang, Guangbo Zhang, Tongguo Shi and Weichang Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:326
    Content type: Research Published on:

  14. Mitochondrial DNA (mtDNA) pathogenic variants have been reported in several solid tumors including ovarian cancer (OC), the most lethal gynecologic malignancy, and raised interest as they potentially induce mi...

    Authors: Daniele Boso, Ilaria Piga, Chiara Trento, Sonia Minuzzo, Eleonora Angi, Luisa Iommarini, Elisabetta Lazzarini, Leonardo Caporali, Claudio Fiorini, Luigi D’Angelo, Monica De Luise, Ivana Kurelac, Matteo Fassan, Anna Maria Porcelli, Filippo Navaglia, Ilaria Billato…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:325
    Content type: Research Published on:

  15. Thymic epithelial tumors (TETs) are infrequent malignancies that arise from the anterior mediastinum. Therapeutic options for TETs, especially thymic carcinoma (TC), remain relatively constrained. This study a...

    Authors: Haoran E, Lei Zhang, Zhenhua Yang, Long Xu, Tao Wang, Junhong Guo, Lang Xia, Juemin Yu, Heyong Wang, Yunlang She, Junqi Wu, Yue Zhao, Chang Chen and Deping Zhao
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:324
    Content type: Research Published on:

  16. Cancer-associated fibroblasts (CAFs) represent a group of genotypically non-malignant stromal cells in the tumor micro-environment (TME) of solid tumors that encompasses up to 80% of the tumor volume. Even tho...

    Authors: Kris T. P. M. Raaijmakers, Gosse J. Adema, Johan Bussink and Marleen Ansems
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:323
    Content type: Review Published on:

  17. Multiple myeloma (MM), a hematologic malignancy characterized by the clonal expansion of plasma cells within the bone marrow, is associated with severe health complications, including osteolytic bone lesions t...

    Authors: Tiziana Bruno, Valeria Catena, Giovanni Blandino, Maurizio Fanciulli and Silvia Di Agostino
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:322
    Content type: Commentary Published on:

  18. The androgen receptor (AR), a ligand-dependent transcription factor, plays a key role in regulating prostate cancer (PCa) growth. The novel bipolar androgen therapy (BAT) uses supraphysiological androgen level...

    Authors: Julia Kallenbach, Mahdi Rasa, Mehdi Heidari Horestani, Golnaz Atri Roozbahani, Katrin Schindler and Aria Baniahmad
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:321
    Content type: Research Published on:

  20. Liver metastasis poses a significant barrier to effective immunotherapy in patients with colorectal cancer. Cryoablation has emerged as a vital supplementary therapeutic approach for these patients. However, i...

    Authors: Hongtong Tan, Yiquan Jiang, Lujun Shen, Gulijiayina Nuerhashi, Chunyong Wen, Ling Gu, Yujia Wang, Han Qi, Fei Cao, Tao Huang, Ying Liu, Weining Xie, Wuguo Deng and Weijun Fan
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:319
    Content type: Research Published on:

  21. Relapsed head and neck squamous cell carcinoma (HNSCC) unrelated to HPV infection carries a poor prognosis. Novel approaches are needed to improve the clinical outcome and prolong survival in this patient popu...

    Authors: Lucas A. Horn, Hanne Lind, Kristen Fousek, Haiyan Qin, Nika Rajabian, Shantel Angstadt, Nicole Hsiao-Sanchez, Miriam M. Medina-Enriquez, Marcus D. Kelly, Clint T. Allen, Sarah M. Hammoudeh, Roberto Weigert, Dean Y. Maeda, John A. Zebala and Claudia Palena
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:318
    Content type: Research Published on:

  22. Acral melanoma (AM) is an aggressive melanoma variant that arises from palmar, plantar, and nail unit melanocytes. Compared to non-acral cutaneous melanoma (CM), AM is biologically distinct, has an equal incid...

    Authors: Eric A. Smith, Rachel L. Belote, Nelly M. Cruz, Tarek E. Moustafa, Carly A. Becker, Amanda Jiang, Shukran Alizada, Anastasia Prokofyeva, Tsz Yin Chan, Tori A. Seasor, Michael Balatico, Emilio Cortes-Sanchez, David H. Lum, John R. Hyngstrom, Hanlin Zeng, Dekker C. Deacon…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:317
    Content type: Research Published on:

  23. Cells from the tumor microenvironment (TME) interact with tumor cells in non-small cell lung cancer (NSCLC) to form a reciprocal crosstalk which influences tumor growth, proliferation, metastasis and multidrug...

    Authors: Antonios N. Gargalionis, Kostas A. Papavassiliou, Efthimia K. Basdra and Athanasios G. Papavassiliou
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:316
    Content type: Commentary Published on:

  24. Ferroptosis is a type of regulated cell death characterized by its non-apoptotic, iron-dependent and oxidative nature. Since its discovery in 2012, extensive research has demonstrated its pivotal roles in tumo...

    Authors: Kaisa Cui, Kang Wang and Zhaohui Huang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:315
    Content type: Review Published on:

  25. Triple-negative breast cancer (TNBC) is currently the most aggressive subtype of breast cancer, characterized by high heterogeneity and strong invasiveness, and currently lacks effective therapies. PRMT5, a ty...

    Authors: Yaxun Guo, Yuzhan Li, Zhongmei Zhou, Lei Hou, Wenjing Liu, Wenlong Ren, Dazhao Mi, Jian Sun, Xueqin Dai, Yingying Wu, Zhuo Cheng, Tingyue Wu, Qianmei Luo, Cong Tian, Fubing Li, Zhigang Yu…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:314
    Content type: Research Published on:

  26. AKT, or protein kinase B, is a central node of the PI3K signaling pathway that is pivotal for a range of normal cellular physiologies that also underlie several pathological conditions, including inflammatory ...

    Authors: Dalal Hassan, Craig W. Menges, Joseph R. Testa and Alfonso Bellacosa
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:313
    Content type: Review Published on:

  27. Breast cancer (BC) is the most frequently diagnosed malignancy among women. It is characterized by a high level of heterogeneity that emerges from the interaction of several cellular and soluble components in ...

    Authors: Ali Mussa, Nor Hayati Ismail, Mahasin Hamid, Mohammad A. I. Al-Hatamleh, Anthony Bragoli, Khalid Hajissa, Noor Fatmawati Mokhtar, Rohimah Mohamud, Vuk Uskoković and Rosline Hassan
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:312
    Content type: Review Published on:

  28. Glioblastoma (GBM), an incurable primary brain tumor, typically requires surgical intervention followed by chemoradiation; however, recurrences remain fatal. Our previous work demonstrated that a nanomedicine ...

    Authors: Chiara Bastiancich, Emmanuel Snacel-Fazy, Samantha Fernandez, Stéphane Robert, Roberta Stacchini, Léa Plantureux, Sébastien Boissonneau, Benoit Testud, Benjamin Guillet, Franck Debarbieux, Hervé Luche, Dominique Figarella-Branger, Marie-Anne Estève, Emeline Tabouret and Aurélie Tchoghandjian
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:311
    Content type: Research Published on:

  29. Approximately half of all human cancers harbour mutations in the p53 gene, leading to the generation of neomorphic p53 mutant proteins. These mutants can exert gain-of-function (GOF) effects, potentially promo...

    Authors: Sabrina Caporali, Alessio Butera, Alessia Ruzza, Carlotta Zampieri, Marina Bantula’, Sandra Scharsich, Anna-Katerina Ückert, Ivana Celardo, Ian U. Kouzel, Luigi Leanza, Andreas Gruber, Joan Montero, Angelo D’Alessandro, Thomas Brunner, Marcel Leist and Ivano Amelio
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:310
    Content type: Research Published on:

  30. The marine drug trabectedin has shown unusual effectiveness in the treatment of myxoid liposarcoma (MLPS), a liposarcoma characterized by the expression of the FUS-DDIT3 chimera. Trabectedin elicits a signific...

    Authors: Ilaria Craparotta, Laura Mannarino, Riccardo Zadro, Sara Ballabio, Sergio Marchini, Giulio Pavesi, Marta Russo, Salvatore Lorenzo Renne, Marina Meroni, Marianna Ponzo, Ezia Bello, Roberta Sanfilippo, Paolo G. Casali, Maurizio D’Incalci and Roberta Frapolli
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:309
    Content type: Research Published on:

  31. Basket clinical trials targeting the KRASG12C-mutation in solid tumors have shown initial promise, including in orphan KRASG12C head and neck cancer (HNC). However, development of resistance to KRASG12C-mutant-sp...

    Authors: Ofra Novoplansky, Sankar Jagadeeshan, Manu Prasad, Ksenia M. Yegodayev, Divyasree Marripati, Raghda Abu Shareb, Yariv Greenshpan, Sooraj Mathukkada, Talal Ben-Lulu, Baisali Bhattacharya, Angel Porgador, Dexin Kong, Johannes Brägelmann, J. Silvio Gutkind and Moshe Elkabets
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:308
    Content type: Research Published on:

  32. Triple-negative breast cancer (TNBC) has pronounced stemness that is associated with relapse. N6-methyladenosine (m6A) plays a crucial role in shaping cellular behavior by modulating transcript expression. Howeve...

    Authors: Xupeng Bai, Jiarui Liu, Shujie Zhou, Lingzhi Wu, Xiaojie Feng and Pumin Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:307
    Content type: Research Published on:

  33. The response of hepatocellular carcinoma (HCC) to transarterial chemoembolization (TACE) treatment and its underlying mechanisms remain elusive. This study investigates the role of enzymes involved in fatty ac...

    Authors: Ji Feng, Jin-Lian Bin, Xi-Wen Liao, Yong Wu, Yue Tang, Pei-Zhi Lu, Guang-Zhi Zhu, Qian-Ru Cui, Yock Young Dan, Guo-Huan Yang, Li-Xin Li, Jing-Huan Deng, Tao Peng, Shing Chuan Hooi, Jing Zhou and Guo-Dong Lu
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:306
    Content type: Research Published on:

  34. LncRNAs play essential roles in multiple tumors. However, research on genome-wide lncRNA alterations and their functions in cervical cancer (CC) is limited. This study aims to explore key lncRNAs in CC progres...

    Authors: Xing Zhang, Wenjing Yan, Hua Jin, Bingjia Yu, Hao Zhang, Bo Ding, Xue Chen, Yan Zhang, Qianqian Xia, Dan Meng, Jing Hu, Haohan Liu, Yamei Nie, Fengying Liu, Yun Zheng, Yiran Lu…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:305
    Content type: Research Published on:

  35. Sphingosine-1-phosphate receptor 1 (S1PR1) is considered to be closely related to a variety of malignant tumors, but the role and mechanism of S1PR1 in lung adenocarcinoma are not fully understood. In this stu...

    Authors: Yanfei Chai, Hong Xiang, Yuchao Ma, Wei Feng, Zhibin Jiang, Qianjun Zhu, Yingji Chen, Quanjun Liu, Jing Zhang, Jie Ouyang, Peng Gao, Xiao Zhang, Shuhua Chen, Longyu Jin and Hongwei Lu
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:304
    Content type: Research Published on:

  36. Bladder cancer (BLCA) is a common malignancy characterized by dysregulated transcription and a lack of effective therapeutic targets. In this study, we aimed to identify and evaluate novel targets with clinica...

    Authors: Lisi Zheng, Jingxuan Wang, Shan Han, Li Zhong, Zefu Liu, Bin Li, Ruhua Zhang, Liwen Zhou, Xianchong Zheng, Zhenhua Liu, Cuiling Zeng, Ruonan Li, Yezi Zou, Liqin Wang, Yuanzhong Wu and Tiebang Kang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:303
    Content type: Research Published on:

  37. Overcoming resistance to Osimertinib in epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) is clinically challenging because the underlying mechanisms are not fully understood. T...

    Authors: Jiaxin Liu, Lingyun Wei, Qing Miao, Sutong Zhan, Peilin Chen, Wei Liu, Liang Cao, Dong Wang, Hongbing Liu, Jie Yin, Yong Song, Mingxiang Ye and Tangfeng Lv
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:302
    Content type: Research Published on:

  38. Authors: Tong Xu, Chaozhuang Zhu, Jinming Chen, Feifeng Song, Xinxin Ren, Shanshan Wang, Xiaofen Yi, Yiwen Zhang, Wanli Zhang, Qing Hu, Hui Qin, Yujia Liu, Song Zhang, Zhuo Tan, Zongfu Pan, Ping Huang…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:301
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2023 42:182

  39. Authors: Yunzhi Liu, Qishan Xu, Fan Deng, Zhuojun Zheng, Jialiang Luo, Ping Wang, Jia Zhou, Xiao Lu, Liyun Zhang, Zhengliang Chen, Qifan Zhang, Qingyun Chen and Daming Zuo
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:300
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2023 42:38

  40. Patients with metastatic hepatoblastoma are treated with severely toxic first-line chemotherapies in combination with surgery. Yet, inadequate response of lung metastases to neo-adjuvant chemotherapy still com...

    Authors: Salih Demir, Alina Hotes, Tanja Schmid, Stefano Cairo, Emilie Indersie, Claudio Pisano, Eiso Hiyama, Tomoro Hishiki, Christian Vokuhl, Sophie Branchereau, Penelope Brock, Irene Schmid, József Zsiros and Roland Kappler
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:299
    Content type: Research Published on:

  41. The major breakthrough in cancer therapy with immune checkpoint inhibitors (ICIs) has highlighted the important role of immune checkpoints in antitumoral immunity. However, most patients do not achieve durable...

    Authors: Joao Gorgulho, Sven H. Loosen, Ramsha Masood, Franziska Giehren, Francesca Pagani, Gustav Buescher, Lorenz Kocheise, Vincent Joerg, Constantin Schmidt, Kornelius Schulze, Christoph Roderburg, Eva Kinkel, Britta Fritzsche, Simon Wehmeyer, Benjamin Schmidt, Paul Kachel…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:298
    Content type: Research Published on:

  42. A limitation of approved oncolytic viruses is their requirement for intratumoral (i.t.) injection. TILT-123 (igrelimogene litadenorepvec, Ad5/3-E2F-D24-hTNFα-IRES-hIL-2) is a chimeric oncolytic adenovirus suit...

    Authors: Elise Jirovec, Dafne C. A. Quixabeira, James H. A. Clubb, Santeri A. Pakola, Tatiana Kudling, Victor Arias, Lyna Haybout, Katriina Jalkanen, Tuomo Alanko, Tine Monberg, Amir Khammari, Brigitte Dreno, Inge Marie Svane, Matthew S. Block, Daniel A. Adamo, Johanna Mäenpää…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:297
    Content type: Research Published on:

  43. Prevention and treatment of metastatic breast cancer (BC) is an unmet clinical need. The retinoic acid derivative fenretinide (FeR) was previously evaluated in Phase I-III clinical trials but, despite its exce...

    Authors: Maria Laura De Angelis, Federica Francescangeli, Eleonora Aricò, Paola Verachi, Massimo Zucchetti, Cristina Matteo, Elena Petricci, Emanuela Pilozzi, Isabella Orienti, Alessandra Boe, Adriana Eramo, Rachele Rossi, Tiberio Corati, Daniele Macchia, Anna Maria Pacca, Ann Zeuner…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:296
    Content type: Research Published on:

  44. Immune checkpoint inhibitors (ICI) have dramatically improved the life expectancy of patients with metastatic melanoma. However, about half of the patient population still present resistance to these treatment...

    Authors: Juliano Tiburcio de Freitas, Varsha Thakur, Kathryn M. LaPorte, Vijay S. Thakur, Brian Flores, Valentina Caicedo, Chioma G. E. Ajaegbu, Giuseppe Ingrasci, Zoe M. Lipman, Keman Zhang, Hong Qiu, Thomas R. Malek and Barbara Bedogni
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:295
    Content type: Research Published on:

  45. Among blood cancers, multiple myeloma (MM) represents the second most common neoplasm and is characterized by the accumulation and proliferation of monoclonal plasma cells within the bone marrow. Despite the l...

    Authors: Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli, Jessica Faletti, Davide Capoferri, Raffaella Marcheselli, Margherita Sciumè, Marco Presta, Antonio Sacco and Aldo M. Roccaro
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:294
    Content type: Review Published on:

  47. Checkpoint immunotherapy unleashes tumor control by T cells, but it is undermined in non-immunogenic tumors, e.g. with low MHC class I expression and low neoantigen burden, such as neuroblastoma (NB). Endoplas...

    Authors: Patrizia Tempora, Silvia D’Amico, Paula Gragera, Verena Damiani, Kamila Krol, Valentina Scaldaferri, Kirti Pandey, Shanzou Chung, Valeria Lucarini, Ezio Giorda, Marco Scarsella, Gabriele Volpe, Marco Pezzullo, Cristiano De Stefanis, Valentina D’Oria, Lorenzo De Angelis…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:292
    Content type: Research Published on:

  48. Authors: Lu Liu, Nayiyuan Wu, Ying Wang, Xiaoyun Zhang, Bing Xia, Jie Tang, Jingting Cai, Zitong Zhao, Qianjin Liao and Jing Wang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:291
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:106

  49. Monocyte Chemotactic Protein 1-Induced Protein 1 (MCPIP1, also called Regnase-1) is a negative modulator of inflammation with tumor-suppressive properties. Mice with keratinocyte-specific deletion of the Zc3h12a ...

    Authors: Agata Lichawska-Cieslar, Weronika Szukala, Guillem Ylla, Gabriela Machaj, Faustyna Ploskonka, Iwona Chlebicka, Jacek C. Szepietowski and Jolanta Jura
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:290
    Content type: Research Published on:

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 11.4
    5-year Journal Impact Factor: 11.4
    Source Normalized Impact per Paper (SNIP): 1.770
    SCImago Journal Rank (SJR): 2.806

    Speed 2024
    Submission to first editorial decision (median days): 2
    Submission to acceptance (median days): 96

    Usage 2024
    Downloads: 4,059,655
    Altmetric mentions: 2,197

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us